AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.

See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.

SG acquires AstraZeneca's Evusheld

Evusheld is a long-acting antibody candidate for COVID-19 treatment.

AstraZeneca SG signs MOU with tech partners

The partnerships aim to improve care delivery and patient outcomes.